Improvement in hyperprolactinemia and reproductive comorbidities in patients with schizophrenia switched from conventional antipsychotics or risperidone to olanzapine.

Kinon BJ, Ahl J, Liu-Seifert H, Maguire GA. Improvement in hyperprolactinemia and reproductive comorbidities in patients with schizophrenia switched from conventional antipsychotics or risperidone to olanzapine. Psychoneuroendocrinology. 2006;31(5):577-88. DOI: 10.1016/j.psyneuen.2005.12.006. PubMed PMID: 16488084.

Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.

Lu M-L, Shen WW, Chen C-H. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(8):1978-81. DOI: 10.1016/j.pnpbp.2008.09.016. PubMed PMID: 18848860.

Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone.

Kim K-S, Pae C-U, Chae J-H, Bahk W-M, Jun T-Y, Kim D-J, et al. Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone. J Clin Psychiatry. 2002;63(5):408-13. PubMed PMID: 12019665.

Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study.

Byerly MJ, Marcus RN, Tran Q-V, Eudicone JM, Whitehead R, Baker RA. Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study. Schizophr Res. 2009;107(2-3):218-22. DOI: 10.1016/j.schres.2008.09.019. PubMed PMID: 19038534.

Dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia.

Yasui-Furukori N, Furukori H, Sugawara N, Fujii A, Kaneko S. Dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia. J Clin Psychopharmacol. 2010;30(5):596-9. DOI: 10.1097/JCP.0b013e3181ee832d. PubMed PMID: 20814333.

Preliminary report: a naturalistic study of the effect of aripiprazole addition on risperidone-related hyperprolactinemia in patients treated with risperidone long-acting injection.

van Kooten M, Arends J, Cohen D. Preliminary report: a naturalistic study of the effect of aripiprazole addition on risperidone-related hyperprolactinemia in patients treated with risperidone long-acting injection. J Clin Psychopharmacol. 2011;31(1):126-8. DOI: 10.1097/JCP.0b013e318205e1aa. PubMed PMID: 21192158.

Amisulpride-induced hyperprolactinaemia is not reversed by addition of aripiprazole.

Paulzen M, Gründer G. Amisulpride-induced hyperprolactinaemia is not reversed by addition of aripiprazole. Int J Neuropsychopharmacol. 2007;10(1):149-51. DOI: 10.1017/S1461145706007115. PubMed PMID: 16942633.

Cabergoline treatment of risperidone-induced hyperprolactinemia: a pilot study.

Cavallaro R, Cocchi F, Angelone SM, Lattuada E, Smeraldi E. Cabergoline treatment of risperidone-induced hyperprolactinemia: a pilot study. J Clin Psychiatry. 2004;65(2):187-90. PubMed PMID: 15003071.

Effects of cabergoline on hyperprolactinemia, psychopathology, and sexual functioning in schizophrenic patients.

Kalkavoura CS, Michopoulos I, Arvanitakis P, Theodoropoulou P, Dimopoulou K, Tzebelikos E, et al. Effects of cabergoline on hyperprolactinemia, psychopathology, and sexual functioning in schizophrenic patients. Exp Clin Psychopharmacol. 2013;21(4):332-41. DOI: 10.1037/a0033448. PubMed PMID: 23834553.

Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study.

Chen J-X, Su Y-A, Bian Q-T, Wei L-H, Zhang R-Z, Liu Y-H, et al. Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study. Psychoneuroendocrinology. 2015;58:130-40. DOI: 10.1016/j.psyneuen.2015.04.011. PubMed PMID: 25981348.